US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 8.501
  • +0.181+2.17%
Trading Apr 29 12:31 ET
1.78BMarket Cap-19.77P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
36.00%450.71M
40.83%131.53M
34.98%117.09M
32.54%109.33M
34.87%92.76M
22.37%331.41M
17.42%93.4M
14.39%86.74M
25.88%82.49M
37.77%68.78M
Operating revenue
36.00%450.71M
42.50%137.24M
35.75%116.32M
32.54%109.33M
34.87%92.76M
22.37%331.41M
21.07%96.31M
13.00%85.68M
25.88%82.49M
38.38%68.78M
Cost of revenue
167.86%12.49M
274.53%6.13M
184.15%3.23M
82.53%1.73M
48.40%1.39M
-29.31%4.66M
-34.42%1.64M
-68.56%1.14M
284.62%950K
294.12%938K
Gross profit
34.12%438.23M
36.66%125.4M
33.00%113.86M
31.96%107.6M
34.68%91.37M
23.66%326.75M
19.10%91.76M
18.54%85.61M
24.90%81.54M
36.54%67.84M
Operating expense
2.40%440.77M
-3.36%129.91M
8.86%106.17M
-3.33%98.84M
9.98%105.86M
4.31%430.46M
8.98%134.43M
8.78%97.53M
2.24%102.24M
-3.40%96.26M
Selling and administrative expenses
24.42%266.13M
24.99%80.47M
28.50%65.08M
20.03%61.21M
24.02%59.36M
34.21%213.89M
28.37%64.38M
37.19%50.65M
34.14%51M
39.63%47.87M
Research and development costs
-19.36%174.64M
-29.42%49.44M
-12.37%41.08M
-26.58%37.62M
-3.92%46.49M
-14.50%216.57M
-4.31%70.05M
-11.11%46.88M
-17.33%51.25M
-25.97%48.39M
Operating profit
97.55%-2.54M
89.44%-4.51M
164.52%7.69M
142.32%8.76M
49.01%-14.49M
30.13%-103.71M
7.86%-42.67M
31.67%-11.92M
40.37%-20.7M
43.12%-28.42M
Net non-operating interest income expense
9.40%-83.77M
-3.78%-20.88M
8.31%-21.24M
15.84%-21.18M
14.75%-20.48M
1.60%-92.46M
15.31%-20.12M
-0.63%-23.16M
-7.48%-25.17M
-0.99%-24.02M
Non-operating interest income
-6.53%14.75M
-20.04%3.57M
-14.17%3.59M
-5.23%3.55M
19.33%4.03M
207.72%15.78M
65.13%4.47M
137.73%4.18M
515.76%3.75M
6,155.56%3.38M
Non-operating interest expense
-8.98%98.52M
-0.55%24.45M
-9.20%24.83M
-14.46%24.73M
-10.55%24.51M
9.23%108.24M
-7.09%24.58M
10.37%27.35M
20.37%28.92M
14.93%27.4M
Other net income (expense)
97.87%-641K
-61.50%-604K
113.30%98K
99.71%-84K
77.73%-51K
-1,415.78%-30.06M
73.29%-374K
-36.99%-737K
-21,856.06%-28.72M
-29.38%-229K
Gain on sale of security
38.31%-641K
-61.50%-604K
113.30%98K
-127.91%-84K
77.73%-51K
47.60%-1.04M
73.29%-374K
-36.99%-737K
128.03%301K
-29.38%-229K
Special income (charges)
--0
--0
--0
--0
----
---29.02M
--0
--0
---29.02M
----
-Less:Other special charges
----
----
----
----
----
--29.02M
--0
----
--29.02M
----
Income before tax
61.56%-86.95M
58.85%-25.99M
62.46%-13.45M
83.24%-12.5M
33.51%-35.01M
7.43%-226.23M
11.62%-63.16M
12.63%-35.82M
-28.59%-74.59M
28.76%-52.66M
Income tax
521.61%1.93M
156.18%804K
77.58%586K
-76.76%172K
-45.60%365K
-88.66%310K
-1,982.89%-1.43M
-78.32%330K
-13.55%740K
140.50%671K
Net income
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
Net income continuous Operations
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
Minority interest income
Net income attributable to the parent company
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
Basic earnings per share
63.56%-0.43
58.06%-0.13
63.16%-0.07
85.00%-0.06
39.29%-0.17
11.28%-1.18
18.42%-0.31
17.39%-0.19
-25.00%-0.4
30.00%-0.28
Diluted earnings per share
63.56%-0.43
58.06%-0.13
63.16%-0.07
85.00%-0.06
39.29%-0.17
11.28%-1.18
18.42%-0.31
17.39%-0.19
-25.00%-0.4
30.00%-0.28
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 36.00%450.71M40.83%131.53M34.98%117.09M32.54%109.33M34.87%92.76M22.37%331.41M17.42%93.4M14.39%86.74M25.88%82.49M37.77%68.78M
Operating revenue 36.00%450.71M42.50%137.24M35.75%116.32M32.54%109.33M34.87%92.76M22.37%331.41M21.07%96.31M13.00%85.68M25.88%82.49M38.38%68.78M
Cost of revenue 167.86%12.49M274.53%6.13M184.15%3.23M82.53%1.73M48.40%1.39M-29.31%4.66M-34.42%1.64M-68.56%1.14M284.62%950K294.12%938K
Gross profit 34.12%438.23M36.66%125.4M33.00%113.86M31.96%107.6M34.68%91.37M23.66%326.75M19.10%91.76M18.54%85.61M24.90%81.54M36.54%67.84M
Operating expense 2.40%440.77M-3.36%129.91M8.86%106.17M-3.33%98.84M9.98%105.86M4.31%430.46M8.98%134.43M8.78%97.53M2.24%102.24M-3.40%96.26M
Selling and administrative expenses 24.42%266.13M24.99%80.47M28.50%65.08M20.03%61.21M24.02%59.36M34.21%213.89M28.37%64.38M37.19%50.65M34.14%51M39.63%47.87M
Research and development costs -19.36%174.64M-29.42%49.44M-12.37%41.08M-26.58%37.62M-3.92%46.49M-14.50%216.57M-4.31%70.05M-11.11%46.88M-17.33%51.25M-25.97%48.39M
Operating profit 97.55%-2.54M89.44%-4.51M164.52%7.69M142.32%8.76M49.01%-14.49M30.13%-103.71M7.86%-42.67M31.67%-11.92M40.37%-20.7M43.12%-28.42M
Net non-operating interest income expense 9.40%-83.77M-3.78%-20.88M8.31%-21.24M15.84%-21.18M14.75%-20.48M1.60%-92.46M15.31%-20.12M-0.63%-23.16M-7.48%-25.17M-0.99%-24.02M
Non-operating interest income -6.53%14.75M-20.04%3.57M-14.17%3.59M-5.23%3.55M19.33%4.03M207.72%15.78M65.13%4.47M137.73%4.18M515.76%3.75M6,155.56%3.38M
Non-operating interest expense -8.98%98.52M-0.55%24.45M-9.20%24.83M-14.46%24.73M-10.55%24.51M9.23%108.24M-7.09%24.58M10.37%27.35M20.37%28.92M14.93%27.4M
Other net income (expense) 97.87%-641K-61.50%-604K113.30%98K99.71%-84K77.73%-51K-1,415.78%-30.06M73.29%-374K-36.99%-737K-21,856.06%-28.72M-29.38%-229K
Gain on sale of security 38.31%-641K-61.50%-604K113.30%98K-127.91%-84K77.73%-51K47.60%-1.04M73.29%-374K-36.99%-737K128.03%301K-29.38%-229K
Special income (charges) --0--0--0--0-------29.02M--0--0---29.02M----
-Less:Other special charges ----------------------29.02M--0------29.02M----
Income before tax 61.56%-86.95M58.85%-25.99M62.46%-13.45M83.24%-12.5M33.51%-35.01M7.43%-226.23M11.62%-63.16M12.63%-35.82M-28.59%-74.59M28.76%-52.66M
Income tax 521.61%1.93M156.18%804K77.58%586K-76.76%172K-45.60%365K-88.66%310K-1,982.89%-1.43M-78.32%330K-13.55%740K140.50%671K
Net income 60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M
Net income continuous Operations 60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M
Minority interest income
Net income attributable to the parent company 60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M
Basic earnings per share 63.56%-0.4358.06%-0.1363.16%-0.0785.00%-0.0639.29%-0.1711.28%-1.1818.42%-0.3117.39%-0.19-25.00%-0.430.00%-0.28
Diluted earnings per share 63.56%-0.4358.06%-0.1363.16%-0.0785.00%-0.0639.29%-0.1711.28%-1.1818.42%-0.3117.39%-0.19-25.00%-0.430.00%-0.28
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Disney
DIS
91.145
Adobe
ADBE
371.710
Taiwan Semiconductor
TSM
164.710
4
Intel
INTC
20.660
5
Alibaba
BABA
119.230
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.